You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antitumor Activity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Changsha (BEBT-109)

Completed
  • NSCLC
  • Changsha, Hunan, China
    Hunan Cancer hospital
Aug 20, 2023

Advanced Solid Tumors Trial (SIM0348)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Feb 6, 2023

Advanced Cancer, Metastatic Solid Tumor, Solid Tumor Trial (TACH101)

Recruiting
  • Advanced Cancer
  • +2 more
  • Austin, Texas
    NEXT Oncology
Jan 25, 2023

Solid Tumors Trial (BGB-B167, Tislelizumab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Dec 1, 2022

Advanced Solid Tumors Trial in Shanghai, Tianjin (FHND5071)

Enrolling by invitation
  • Advanced Solid Tumors
  • Shanghai, China
  • +1 more
Apr 17, 2023

Solid Tumor, Adult Trial in Chisinau, Madrid, Pamplona (GEN1056)

Recruiting
  • Solid Tumor, Adult
  • GEN1056
  • Chisinau, Moldova, Republic of
  • +2 more
Dec 9, 2022

Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • (no location specified)
Dec 15, 2022

Solid Tumor Trial (JYB1907)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Apr 6, 2023

Advanced Cancer Trial in Australia (AK-105)

Active, not recruiting
  • Advanced Cancer
  • AK-105
  • Darlinghurst, New South Wales, Australia
  • +4 more
Oct 20, 2022

Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)

Recruiting
  • Solid Tumor
  • B-Raf Mutation-Related Tumors
  • Boston, Massachusetts
  • +4 more
Oct 25, 2022

Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Shanghai, China
    复旦大学附属中山医院
Mar 23, 2023

Tumors Trial in Worldwide (Letetresgene autoleucel)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel
  • Pittsburgh, Pennsylvania
  • +5 more
Aug 7, 2023

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Hackensack, New Jersey
  • +10 more
Jun 6, 2023

Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)

Not yet recruiting
  • Acral Melanoma
  • Mucosal Melanoma
  • Pembrolizumab, Vactosertib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 23, 2022

Advanced Malignant Solid Tumors Trial in Beijing (9MW2821)

Recruiting
  • Advanced Malignant Solid Tumors
  • Beijing, Beijing, China
  • +1 more
Mar 6, 2023

Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)

Not yet recruiting
  • Gastrointestinal Tumors
  • AZD6422 CLDN18.2 CAR-T product
  • Beijing, China
    Beijing Cancer Hospital
Aug 1, 2023

Advanced Solid Tumor Trial in Hangzhou (BR101)

Recruiting
  • Advanced Solid Tumor
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University Medical Co
Aug 14, 2023

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jul 12, 2022

Advanced Solid Tumor Trial in Beijing (QLS12004)

Not yet recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
    The Fifth Medical Center of the General Hospital of the Chinese
Apr 13, 2023

MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

Not yet recruiting
  • MSI-H/dMMR Gastroesophageal-junction Cancer
  • MSI-H/dMMR Gastric Cancer
  • (no location specified)
Oct 30, 2023

Solid Tumor, Adult Trial in Xi'an (Bio-008)

Recruiting
  • Solid Tumor, Adult
  • Bio-008
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of the Chinese People's Liberation
Aug 30, 2023

Locally Advanced Unresectable or Metastatic Solid Tumor Trial in China, United States (SIM0237)

Recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumor
  • Indianapolis, Indiana
  • +7 more
Mar 10, 2023

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Locally Advanced/Metastatic Solid Tumors Trial (PE0116&PE0105)

Not yet recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • (no location specified)
Mar 24, 2023